CELU
Price
$2.08
Change
+$0.16 (+8.33%)
Updated
Jun 6 closing price
Capitalization
49.81M
CYBN
Price
$8.90
Change
+$0.08 (+0.91%)
Updated
Jun 6 closing price
Capitalization
188.13M
Interact to see
Advertisement

CELU vs CYBN

Header iconCELU vs CYBN Comparison
Open Charts CELU vs CYBNBanner chart's image
Celularity
Price$2.08
Change+$0.16 (+8.33%)
Volume$106.12K
Capitalization49.81M
Cybin
Price$8.90
Change+$0.08 (+0.91%)
Volume$324.58K
Capitalization188.13M
CELU vs CYBN Comparison Chart
Loading...
CELU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELU vs. CYBN commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELU is a Hold and CYBN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (CELU: $2.35 vs. CYBN: $8.10)
Brand notoriety: CELU and CYBN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELU: 22% vs. CYBN: 214%
Market capitalization -- CELU: $49.81M vs. CYBN: $188.13M
CELU [@Biotechnology] is valued at $49.81M. CYBN’s [@Biotechnology] market capitalization is $188.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELU’s FA Score shows that 0 FA rating(s) are green whileCYBN’s FA Score has 1 green FA rating(s).

  • CELU’s FA Score: 0 green, 5 red.
  • CYBN’s FA Score: 1 green, 4 red.
According to our system of comparison, both CELU and CYBN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELU’s TA Score shows that 6 TA indicator(s) are bullish while CYBN’s TA Score has 5 bullish TA indicator(s).

  • CELU’s TA Score: 6 bullish, 4 bearish.
  • CYBN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CELU is a better buy in the short-term than CYBN.

Price Growth

CELU (@Biotechnology) experienced а +11.90% price change this week, while CYBN (@Biotechnology) price change was +15.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYBN($188M) has a higher market cap than CELU($49.8M). CELU YTD gains are higher at: 12.981 vs. CYBN (-8.163). CELU has higher annual earnings (EBITDA): -21.59M vs. CYBN (-134.52M). CYBN has more cash in the bank: 136M vs. CELU (133K). CYBN has less debt than CELU: CYBN (0) vs CELU (69.1M). CELU has higher revenues than CYBN: CELU (48.2M) vs CYBN (0).
CELUCYBNCELU / CYBN
Capitalization49.8M188M26%
EBITDA-21.59M-134.52M16%
Gain YTD12.981-8.163-159%
P/E RatioN/AN/A-
Revenue48.2M0-
Total Cash133K136M0%
Total Debt69.1M0-
TECHNICAL ANALYSIS
Technical Analysis
CELUCYBN
RSI
ODDS (%)
Bearish Trend 13 days ago
69%
Bearish Trend 13 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 13 days ago
82%
Bearish Trend 13 days ago
86%
Momentum
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 13 days ago
75%
MACD
ODDS (%)
Bullish Trend 13 days ago
87%
Bullish Trend 13 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 13 days ago
71%
Bullish Trend 13 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
73%
Bullish Trend 13 days ago
68%
Advances
ODDS (%)
Bullish Trend 14 days ago
79%
Bullish Trend 14 days ago
78%
Declines
ODDS (%)
Bearish Trend about 1 month ago
81%
Bearish Trend 27 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
74%
Bearish Trend 13 days ago
90%
Aroon
ODDS (%)
Bullish Trend 13 days ago
66%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CELU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CELU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELU has been loosely correlated with ACOG. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CELU jumps, then ACOG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELU
1D Price
Change %
CELU100%
-1.26%
ACOG - CELU
48%
Loosely correlated
-4.42%
NVCT - CELU
27%
Poorly correlated
N/A
OTLK - CELU
26%
Poorly correlated
+1.24%
SPRO - CELU
26%
Poorly correlated
+244.57%
CYBN - CELU
26%
Poorly correlated
-2.88%
More

CYBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYBN has been loosely correlated with ATAI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CYBN jumps, then ATAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYBN
1D Price
Change %
CYBN100%
-2.88%
ATAI - CYBN
46%
Loosely correlated
+4.52%
ABSI - CYBN
38%
Loosely correlated
+0.74%
ABCL - CYBN
38%
Loosely correlated
+3.03%
RXRX - CYBN
36%
Loosely correlated
+0.11%
EYPT - CYBN
34%
Loosely correlated
+18.12%
More